Read More Healthcare Industry News Suraksha Diagnostic shares jump 13% after Q1 profit rises 40% Suraksha Diagnostic Limited delivered 21% Q1 FY27 income growth, 40% profit growth and a 36% EBITDA margin. A sharp post-results share-price rally now shifts attention to whether new centres and genomics can sustain the operating leverage. bySrinathAugust 17, 2026